JCO Oncology Practice is now accepting manuscripts for a special issue on disparities in cancer care for Hispanic-Latinx people.
Submit your manuscript today at https://www.editorialmanager.com/op-ascopubs/default.aspx
Guest Editors Miguel Villalona-Calero, MD; Gilberto Lopes, MD, MBA; Narjust Duma, MD; and Pelin Cinar, MD, are soliciting papers from all oncology professionals about disparities in genomics, cancer-related access, care, toxicities, social determinants, costs, health economics, and clinical outcomes for Hispanic-Latinx Americans. We understand that Hispanic-Latinx people are not a single race but an ethnicity.
Miguel Villalona-Calero, MD
Gilberto Lopes, MD, MBA
Narjust Duma, MD
Pelin Cinar, MD
This special issue will have six primary areas of focus: Border health and care; immigration and cancer care; access to health and state differences; rural cancer care for the Hispanic-Latinx people; economics of cancer care for Hispanic-Latinx people; and workforce diversity, including trainee pipeline and leadership.
Papers may address any aspect of cancer care, including screening, survivorship, and end of life with associated frameworks and successful models for improving cancer care delivery and work force, generalizable scientific quality improvement projects, cancer care policy, or the business of oncology for Hispanic-Latinx Americans. We will prioritize papers that inform practices about validated approaches to reduce disparities in this population or subpopulations with specific challenges. However, we will not prioritize papers that only demonstrate disparities without a study of potential interventions. This special issue will also include a clinical review of racial disparities in cancer care and commentaries discussing how to promote health equity and address disparities for Hispanic-Latinx people.
Suggested topics include studies that show impacts to address:
We request manuscript submissions by January 15, 2022, for this Spring 2022 Special Issue.
For editorial inquiries and potential publication suitability, contact the JCO OP editorial office at email@example.com.
© 2021. American Society of Clinical Oncology. All rights reserved.